http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012168360-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_558a0124a47860344c4f032857a78c37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_154ddbdadc0077717f44413d600bac9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d59558ec42e4fd33f9895daadacf1abe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7f75780245ab029ad042060276ad22a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7cbceb0f0cfa1236b91b6300f4c949b0
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-522
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-88
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4926
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4946
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q5-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q5-00
filingDate 2012-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45f7a0fc55fc37c06d59db8dab8fdf10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3d38a9783fcc47a076bc5cadd205ba1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f449aa66c891c2bfe8f9235d81ce226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fcf24a1cbdf22bd41014295aa46bc31
publicationDate 2013-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012168360-A3
titleOfInvention Active substance preparations made from εpsilon-polylysine (epsilon-polylsine) and piroctone olamine and/or climbazole
abstract The invention relates to active substance combinations comprising: a) ε-polylysin (epsilon-polylysin) b) piroctone olamine and/or climbazole.
priorityDate 2011-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004035461-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0843002-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012055585-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012055587-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009150090-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1547484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14127907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50258
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44181993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226429123

Total number of triples: 42.